Company Long-Term Loans and Borrowings: Neumora Therapeutics Inc (NMRA)

Brandmark of Neumora Corp (NMRA)

Neumora Therapeutics (NMRA) production processes rely on external contractors with optimized cycles, which eliminates downtime. This biotech operates within the framework of long-term medicine, demonstrating immunity to macroeconomic fluctuations. This chart (separate_debt_long) illustrates the debt load dynamics, which currently stands at 0.06. The company's valuation growth is based on successes in developing depression treatments and the availability of capital for R&D development.

Neumora (NMRA) Company Long-Term Debt: for the period 02/21/2024 - 11/01/2026

Neumora Therapeutics Inc - analytical breakdowns and key metrics (NMRA)

- market price and analyst price targets:
Stock Price neumoratx.com|NMRA - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Neumora Therapeutics|NMRA - Total Company Value
- book capitalization information:
Net Asset Value per Share Neumora Therapeutics|NMRA - Company Book Value|Capitalization to Book Value Ratio neumoratx.com|NMRA - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Neumora Therapeutics|NMRA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Neumora Corp|NMRA - Company Debts|Debt to Book Value Neumora Therapeutics|NMRA - Company Long-Term Debt|Short-Term Debt Neumora Therapeutics|Intermediate Coverage Ratio neumoratx.com
- earnings and market multiples details:
NMRA - Net Profit
Analysis of all company metrics:NMRA - neumoratx.com
Manufactured product of Neumora Therapeutics Inc

Developing innovative brain-treatment drugs requires colossal capital expenditures for years to come. This metric aggregates total obligations with maturities exceeding one year, reflecting the issuer's debt load and financial stability. Monitoring the long-term loans and borrowings of Neumora Therapeutics (NMRA) allows for an assessment of the company's ability to fund R&D without risking a loss of liquidity. The stability of this value confirms the reliability of the capital structure when creating patent-protected products.

Competitors of Neumora Therapeutics (NMRA)

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|Company Long-Term Indebtedness VKTX (vikingtherapeutics.com)|Company Long-Term Debts SUPN|CPRX - Long-Term Debt|Denali Therapeutics Inc - Company Long-Term Liabilities|Company Long-Term Debts Harmony Corp HRMY|BHVN - Company Long-Term Debt|amylyx.com (AMLX) - Company Long-Term Liabilities|Trevi Therapeutics, Inc. (TRVI) - Company Long-Term Debt|Long-Term Debt Praxis Precision Medicines Inc (PRAX)|Company Long-Term Debt Anavex Corp|CBLL: Company Long-Term Loans and Borrowings|Company Long-Term Debts PRTA|Company Long-Term Debts alector.com (ALEC)|Annexon - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMER|NGNE: Company Long-Term Liabilities|AC Immune Inc - Amount of Long-Term Liabilities|VYGR: Company Long-Term Debts|scilexholding.com - Company Long-Term Loans and Borrowings|TVGN (Tevogen Bio) - Company Long-Term Debts|Long-Term Debt Alpha Cognition Corp ACOG|Company Long-Term Debt Cognition Therapeutics (CGTX)|IKT (Inhibikase Pharma) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SAVA (Cassava Sciences, Inc.)|Company Long-Term Debts Assertio Holdings ASRT|COYA - Company Long-Term Debt|Long-Term Liabilities VTGN|OVID: Company Long-Term Debts|Long-Term Debt Acumen Pharmaceuticals, Inc (ABOS)|Company Long-Term Liabilities CRVO|Company Long-Term Debts Alterity Therapeutics Ltd|Company Long-Term Liabilities CLNN (Clene Inc.)|Amount of Long-Term Liabilities PEPG|Company Long-Term Debts JUNS (Jupiter Neurosciences Inc)|Long-Term Debt Volume Relmada Corp (RLMD)|Annovis Bio, Inc. - Company Long-Term Debts|Grace Therapeutics, Inc. (GRCE) - Company Long-Term Liabilities|Firefly Neuroscience (AIFF) - Company Long-Term Debt|KLTO - Long-Term Debt Volume|Company Long-Term Debt NeuroSense Therapeutics Ltd|Company Long-Term Indebtedness RVPH (Reviva Pharmaceuticals, Inc.)|Company Long-Term Debt MetaVia Inc (MTVA)|Company Long-Term Liabilities neuraxis.com NRXS|Company Long-Term Debt Helius Medical Technologies HSDT|Company Long-Term Loans and Borrowings PASG|Neuphoria - Company Long-Term Debts|NERV - Company Long-Term Debts|Athira Pharma, Inc. (ATHA) - Company Long-Term Debt|Company Long-Term Indebtedness ADXN|ALZN (Alzamend Neuro Inc.) - Company Long-Term Debts|Long-Term Debt Cyclerion CYCN|Company Long-Term Liabilities PTIX (Protagenic Therapeutics)|Company Long-Term Debts pasitheaclinics.com (KTTA)|Company Long-Term Debt Cortigent CRGT|Company Long-Term Loans and Borrowings ATXI|BCLI - Company Long-Term Debt|Long-Term Debt Cara Therapeutics Inc.|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Company Long-Term Indebtedness ELYM|ITCI (Intra-Cellular Therapies Inc.) - Company Long-Term Debts|Long-Term Debt longboardpharma.com LBPH|Company Long-Term Liabilities MRNS (Marinus Pharmaceuticals, Inc.)|Company Long-Term Debts NKGen Biotech Inc (NKGN)|Company Long-Term Debt NeuroBo NRBO|SAGE - Company Long-Term Liabilities|SNPX - Company Long-Term Debt|Long-Term Debt trevena.com|vigilneuro.com (VIGL) - Company Long-Term Debt|Anew Medical Inc. - Company Long-Term Loans and Borrowings|CERE (Cerevel) - Company Long-Term Debts